Biosynthesis of plant-specific stilbene polyketides in metabolically engineered Escherichia coli
2006

Biosynthesis of Stilbene Compounds in Engineered E. coli

publication Evidence: moderate

Author Information

Author(s): Kevin T. Watts, Pyung C. Lee, Claudia Schmidt-Dannert

Primary Institution: University of Minnesota

Hypothesis

Can engineered E. coli produce stilbene compounds from phenylpropionic acid precursors?

Conclusion

Recombinant E. coli can efficiently convert phenylpropionic acids into stilbene compounds like resveratrol and piceatannol.

Supporting Evidence

  • Resveratrol was produced at a level of over 100 mg/L in E. coli.
  • Piceatannol was produced at levels around 13 mg/L.
  • Ferulic acid did not yield the expected stilbene product, indicating limitations in the pathway.

Takeaway

Scientists made a type of medicine called stilbene in bacteria instead of plants, which is usually hard to do.

Methodology

The study involved cloning plant genes into E. coli to create a pathway for stilbene biosynthesis and testing various phenylpropionic acids as substrates.

Limitations

The conversion yield of resveratrol was less than 50%, and ferulic acid was not converted to the expected stilbene product.

Digital Object Identifier (DOI)

10.1186/1472-6750-6-22

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication